Skip to content

Can 3% hypertonic saline reduce TBI child mortality and improve long-term neurological outcomes?

Can 3% hypertonic saline reduce TBI child mortality and improve long-term neurological outcomes?

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023523
Enrollment
Unknown
Registered
2019-06-01
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic brain injury

Interventions

Two groups:3% saline versus mannitol

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children under 16 years of age (excluding newborns), with craniocerebral injury within 24 hours of ICU, Glasgow coma score (GCS) 13 with mechanical ventilation patients

Exclusion criteria

Exclusion criteria: Patients with pre-existing neurological disease.

Design outcomes

Primary

MeasureTime frame
Glasgow coma scale;Injury severity score;Hypertonic drug use;Intracranial pressure (ICP) monitoring;

Countries

China

Contacts

Public ContactDang Hongxing

Children's Hospital of Chongqing Medical University

dhxdoc@163.com+86 13647683940

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026